The deal includes $40m upfront,
It is collaborating with Neurimmune AG on an antibody in clinical trials.
To help with the staggered return to work, and Omicron absences, there is now extra time to get your entry in.
Affiliate Ares Trading SA has exercised a fourth licensing option.
It is in phase III clinical trials to treat TTR-mediated amyloidosis.
Their outstanding achievements in UK life sciences have been recognised.
From scientists to local government leaders to community figures, we detail all of those honoured in the county.
He says the OBE honours the ‘world-leading scientific environment here in Cambridge’.
The preventative combination therapy is approved in the US - will the UK follow suit?
Grant Thornton’s Cambridgeshire Ltd report also reveals most profitable.
The LFT will be marketed as MeduFlow by Medusa once approved for sale.
It will trigger a milestone payment to the Chesterford Research Park company.
Unique structures were found in clumps associated with this form of motor neurone disease.
But it is still held up in the government desktop review process.
It aids drug discovery without the need for animal models.